Valuation: Orion Oyj

Market Cap 1.29TCr 1.44TCr 1.19TCr 1.08TCr 2.02TCr 1,37100Cr 2.05TCr 14TCr 5.68TCr 72TCr 5.42TCr 5.31TCr 2,26500Cr P/E 2026 *
22.7x
P/E 2027 * 19.4x
Enterprise Value 1.28TCr 1.43TCr 1.18TCr 1.07TCr 2.01TCr 1,36100Cr 2.04TCr 14TCr 5.64TCr 71TCr 5.38TCr 5.27TCr 2,24800Cr EV / Sales 2026 *
6.08x
EV / Sales 2027 * 5.28x
Free-Float
90.5%
Yield 2026 *
2.14%
Yield 2027 * 2.36%
1 day+0.66%
1 week+5.52%
Current month+11.00%
1 month+11.41%
3 months+16.35%
6 months+32.09%
Current year+45.02%
1 week 86.4
Extreme 86.4
92.3
1 month 75
Extreme 75
92.3
Current year 62.3
Extreme 62.3
92.3
1 year 56.3
Extreme 56.3
92.3
3 years 32.5
Extreme 32.5
92.3
5 years 32.5
Extreme 32.5
92.3
10 years 24.75
Extreme 24.75
92.3
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%+5.52% - - 1.44TCr
-3.07%+0.32%+53.58%+118.68% 1,16500Cr
-1.48%+3.08%+36.87%+74.01% 64TCr
+0.03%-0.04%+24.99%+97.13% 50TCr
-0.31%+3.09%+43.92%+64.55% 38TCr
-1.44%-0.73%+66.18%+40.18% 36TCr
-0.68%+2.65%+22.46%+51.48% 30TCr
-1.20%+3.04%+2.62%+26.97% 27TCr
-1.51%+1.79%+50.31%+61.22% 24TCr
-0.25%+0.34%+29.80%+102.06% 19TCr
Average -0.95%+2.54%+36.75%+70.70% 45.06TCr
Weighted average by Cap. -1.51%+3.17%+40.60%+81.62%

Financials

2026 *2027 *
Net sales 210.49Cr 235.71Cr 194.46Cr 176.22Cr 329.68Cr 22TCr 335.14Cr 2.34TCr 926.43Cr 12TCr 884.61Cr 865.8Cr 37TCr 237.78Cr 266.27Cr 219.66Cr 199.06Cr 372.42Cr 25TCr 378.58Cr 2.64TCr 1.05TCr 13TCr 999.28Cr 978.03Cr 42TCr
Net income 57Cr 64Cr 53Cr 48Cr 89Cr 6.07TCr 91Cr 634.42Cr 251.17Cr 3.18TCr 239.83Cr 234.73Cr 10TCr 67Cr 75Cr 62Cr 56Cr 104.72Cr 7.11TCr 106.45Cr 743.25Cr 294.26Cr 3.72TCr 280.98Cr 275Cr 12TCr
Net Debt -9.46Cr -11Cr -8.74Cr -7.92Cr -15Cr -1.01TCr -15Cr -105.12Cr -42Cr -526.66Cr -40Cr -39Cr -1.66TCr -35Cr -39Cr -32Cr -29Cr -54Cr -3.67TCr -55Cr -383.88Cr -151.98Cr -1.92TCr -145.12Cr -142.04Cr -6.06TCr
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
23/26/23 €91.80 +0.33% 10,721
22/26/22 €91.50 +2.81% 18,608
21/26/21 €89.00 +0.79% 8,811
20/26/20 €88.30 +0.80% 4,240
19/26/19 €87.60 +0.69% 7,138
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
92.00EUR
Average target price
77.33EUR
Spread / Average Target
-15.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Orion Oyj